Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48,694	43,663	46,246	46,128	80,883	56,859
Market Cap Growth	18.43%	-5.58%	0.25%	-42.97%	42.25%	16.86%
Enterprise Value	43,979	39,982	45,142	45,077	79,772	56,254
Last Close Price	82.45	74.03	76.25	74.61	129.55	91.23
PE Ratio	35.60	10.46	32.98	30.31	53.81	69.05
Forward PE	30.32	31.19	28.41	30.35	52.98	43.34
PS Ratio	8.23	8.03	9.23	10.33	15.46	12.96
PB Ratio	4.60	4.34	6.88	7.94	13.86	12.43
P/TBV Ratio	6.23	6.20	9.06	10.59	18.62	18.52
P/FCF Ratio	-	150.61	71.94	47.38	57.51	87.84
P/OCF Ratio	-	80.51	51.63	37.87	46.70	53.93
PEG Ratio	3.24	3.69	2.77	2.95	3.38	3.13
EV/Sales Ratio	7.47	7.35	9.01	10.10	15.25	12.83
EV/EBITDA Ratio	24.75	24.44	27.66	26.81	46.34	39.52
EV/EBIT Ratio	27.15	27.00	30.35	29.24	50.28	42.74
EV/FCF Ratio	-	137.92	70.23	46.30	56.73	86.91
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Debt / EBITDA Ratio	0.40	0.42	0.41	0.40	0.39	0.48
Debt / FCF Ratio	-	2.42	1.07	0.71	0.49	1.07
Asset Turnover	-	0.49	0.57	0.53	0.67	0.64
Inventory Turnover	-	1.12	1.10	0.90	1.63	1.50
Quick Ratio	-	3.13	2.06	1.87	2.07	2.24
Current Ratio	-	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	-	16.64%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	-	8.26%	10.53%	11.47%	12.60%	11.99%
Return on Capital (ROIC)	9.36%	10.19%	13.37%	14.80%	16.81%	16.30%
Return on Capital Employed (ROCE)	-	12.80%	18.20%	21.20%	21.20%	20.70%
Earnings Yield	2.89%	9.56%	3.03%	3.30%	1.86%	1.45%
FCF Yield	-	0.66%	1.39%	2.11%	1.74%	1.14%
Buyback Yield / Dilution	2.54%	1.66%	2.37%	1.11%	0.11%	0.75%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q